from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0229c/-

LFCtreatmentdescriptionclass of inhibitor

-0.266

Amikacinug/mL Amikacintranslation

-0.558

Cap5-10ug/mL Capreomycintranslation

-0.192

Rox10-50 ug/mL Roxithromycintranslation

-0.165

SM2-5 ug/mL Streptomycintranslation

-0.181

Tet5-10 ug/mL Tetracyclinetranslation

0.968

Rif0.2-5ug/mL Rifampicintranscription

0.188

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.859

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.379

CPZ10-50 ug/mL Chlorpromazinerespiration

2.806

Clofazimine10-13 ug/mL Clofaziminerespiration

1.175

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.212

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.582

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.332

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.551

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.769

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.412

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.892

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.503

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.036

KCN5-20 ug/mL Potassium cyaniderespiration

0.657

NaN30.2-2 mM Sodium aziderespiration

-0.307

Nigericin50 uM Nigericinrespiration

0.041

TRC10-150 ug/mL Triclosanrespiration

1.481

TRZ10-25 ug/mL Thioridazinerespiration

2.337

Valinomycin0.5-10 uM Valinomycinrespiration

-0.227

ZnSO42 mM ZnSO4respiration

-0.755

menadione6-10 ug/mL Menadionerespiration

0.206

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.176

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.144

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.639

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.841

NRP_1Non-replicating persistence stage 1dosRassociated

-0.047

Amp0.2mg/mL AmpicillincellWall

-0.016

Cephalexin20-100 ug/mL CephalexincellWall

0.267

Cerulenin0.32-5 ug/mL CerulenincellWall

0.375

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.321

EMB10-20 ug/mL EthambutolcellWall

-0.138

Eta12-40 ug/mL EthionamidecellWall

-0.353

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.105

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.200

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.500

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.512

BZA0.12 mg/mL BenzamidearomaticAmides

-0.573

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.765

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.327

H2O24 mM hydrogen peroxideDNAdamaging

-0.060

Levo10 ug/mL LevofloxacinDNAdamaging

-0.743

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.789

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.158

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.787

UVUV-irradiationDNAdamaging

0.380

ARP41-4 ug/mL Antitubercular compound ARP4?

0.024

Antimycin12.5-50 ug/mL Antimycin A?

0.449

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.356

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.689

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.967

PA8240.2-2 ug/mL PA-824?

-0.242

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.622

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.125

Verapamil50 uM Verapamil?

0.672

mercaptoethanol2 mM 2-Mercaptoethanol?

1.134

methoxatin10-20 ug/mL Methoxatin?